References
- ReginsterJYAntifracture efficacy of currently available therapies for postmenopausal osteoporosisDrugs2011711657821175240
- SolomonDHAvornJKatzJNCompliance with osteoporosis medicationsArch Intern Med2005165202414241916287772
- CooperCBeyond daily dosing: clinical experienceBone200638Suppl 1s13s1716520105
- RosenCJVitamin D insufficiencyN Engl J Med2011364324825421247315
- LeeMKYimSLeeESParkHMVitamin D perception gap survey between postmenopausal women with osteoporosis and physiciansKorean J Bone Metab200714133139 Korean
- ChungHYChinSOKangMIEfficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosisClin Endocrinol (Oxf)201174669970421521310
- ReckerRLipsPFelsenbergDAlendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trialCurr Med Res Opin20062291745175516968578
- Bischoff-FerrariHADietrichTOravEJDawson-HughesBPositive association between 25-hydroxyvitamin D levels and bone mineral density: a population-based study of younger and older adultsAm J Med2004116963463915093761
- CauleyJAParimiNEnsrudKESerum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older menJ Bone Miner Res201025354555319775201
- Institute of MedicineDietary Reference Intakes for Calcium and Vitamin DWashingtonNational Academies Press2011
- National Osteoporosis FoundationPhysician’s guide to the prevention and treatment of osteoporosis2013 Available from: http://www.nof.org/professionals/hcp/clinicians-guideAccessed May 14, 2013
- HolickMFBinkleyNCBischoff-FerrariHAEvaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab20119671911193021646368
- RichterAAntonSEKochPDennettSLThe impact of reducing dose frequency on health outcomesClin Ther20032582307233514512137
- ChungYSLimSKChungHYComparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic womenCalcif Tissue Int200985538939719816648
- ChelVWijnhoveHAHSmitJHOomsMLipsPEfficacy of different doses and time intervals of oral vitamin D supplementation with without calcium in elderly nursing home residentsOsteoporos Int200819566367117874029
- BollandMJGreyAAvenellAGambleGDReidIRCalcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysisBMJ2011342d204021505219
- WagnerDHanwellHESchnablKThe ratio of serum 24, 25-dihydroxyvitamin D(2) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementationJ Steroid Biochem Mol Biol20111263–5727721605672
- Leidig-BrucknerGRothHJBrucknerTLorenzARaueFFrank-RaueKAre commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels-an observational study during clinical practice conditionsOsteoporos Int201122123124020556359
- ViethRVitamin D toxicity, policy, and scienceJ Bone Miner Res200722Suppl 2V64V6818290725
- ViethRChanPCMacFarlaneGDEfficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect levelAm J Clin Nutr200173228829411157326
- SandersKMStuartALWilliamsonEJAnnual high-dose oral vitamin D and falls and fractures in older women. A randomized controlled trialJAMA2010303181815182220460620
- TrivediDDollRKhawKEffect of four monthly oral vitamin D supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trialBMJ2003326738746947512609940
- SmithHAndersonFRaphaelHMaslinPCrozierSCooperCEffect of annual intramuscular vitamin D on fracture risk in elderly men and women: a population-based, randomized, double-blind, placebo-controlled trialRheumatology (Oxford)200746121852185717998225
- CummingsSRKarpfDBHarrisFImprovement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugsAm J Med2002112428128911893367
- GarneroPShihWJGineytsEKalpfDDelmasPDComparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatmentJ Clin Endocrinol Metab1994796169317007989477
- EastellRBartonIHannonRAChinesAGarneroPDelmasPDRelationship of early changes in bone resorption to the reduction in fracture risk with risedronateJ Bone Miner Res20031861051105612817758
- MaxwellJDSeasonal variation in vitamin DProc Nutr1994533533543